Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, announced the kick-off of their participation in the prestigious Hospital-University Research in Health (RHU) program. Designed...
ADC Therapeutics SA announced results from the ongoing pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami) in relapsed or refractory (r/r) Hodgkin lymphoma....
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today...
Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, announced a publication in Cell Reports that demonstrates peptides derived from transposable elements (TEs) – mobile...
Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...
